Cargando…

Treatment Challenges and Survival Analysis of Human Epidermal Growth Factor Receptor 2-positive Breast Cancer in Real World

CONTEXT: Advent of trastuzumab has brought tremendous changes in the survival of human epidermal growth factor receptor 2 (Her2)-positive breast cancer patients. Despite the availability of the drug, it is still out of reach for many patients. There is very limited real world data regarding treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adusumilli, Praveen, Konatam, Meher Lakshmi, Gundeti, Sadashivudu, Bala, Stalin, Maddali, Lakshmi Srinivas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398102/ https://www.ncbi.nlm.nih.gov/pubmed/28469333 http://dx.doi.org/10.4103/0971-5851.203511

Ejemplares similares

Impact of cytogenetics on outcomes in pediatric acute lymphoblastic leukemia
por: Chennamaneni, Rachana, et al.
Publicado: (2018)

Clinicopathological features, treatment and survival outcomes of synovial sarcoma
por: Kuruva, Siva Prasad, et al.
Publicado: (2018)

Trastuzumab-Related Cardiotoxicity in Adjuvant Setting: A Real-World Scenario
por: Shrivastva, Sarita, et al.
Publicado: (2023)

Outcomes of Adult Ewing Sarcoma Treated with Multimodality Therapy: A Single-Institute Experience
por: Chandran, Ravi, et al.
Publicado: (2020)

The Role of Mutation Testing in Patients with Chronic Myeloid Leukemia in Chronic Phase after Imatinib Failure and Their Outcomes after Treatment Modification: Single-institutional Experience Over 13 Years
por: Chaitanya, Puligundla Krishna, et al.
Publicado: (2017)

Managing metastatic renal cell carcinoma-challenges, pitfalls, and outcomes in the real world
por: Kumar, Karnam Ashok, et al.
Publicado: (2016)

Incidence of febrile neutropenia with commonly used chemotherapy regimen in localized breast cancer
por: Palukuri, Nageswara Reddy, et al.
Publicado: (2020)

Complications during Induction Chemotherapy in Acute Promyelocytic Leukemia: An Institutional Experience
por: Yedla, Rajani Priya, et al.
Publicado: (2022)

Prevalence and outcome of epidermal growth factor receptor mutations in non-squamous non-small cell lung cancer patients
por: Kota, Rajesh, et al.
Publicado: (2015)

Clinicopathological features and outcomes in advanced nonsmall cell lung cancer with tailored therapy
por: Bala, Stalin, et al.
Publicado: (2016)

Philadelphia chromosome-positive acute lymphoblastic leukemia: 8 years’ experience from a tertiary care center in India
por: Danthala, Madhav, et al.
Publicado: (2016)

Clinicopathological Features and Outcomes in Primary Central Nervous System Lymphoma: A 10-year Experience
por: Puligundla, Chaitanya Krishna, et al.
Publicado: (2017)

Trends in management of acute lymphoblastic leukemia: Influence of insurance based healthcare and treatment compliance on the outcome of adolescents and adults with acute lymphoblastic leukemia
por: Arigela, Ravi Sankar, et al.
Publicado: (2016)

Impact of treatment protocol on outcome of localized Ewing's sarcoma
por: Nasaka, Srividya, et al.
Publicado: (2016)

Effectiveness of Three Prognostic Scoring Systems in Predicting the Response and Outcome in Pediatric Chronic Myeloid Leukemia Chronic Phase on Frontline Imatinib
por: Ganta, Ranga Raman, et al.
Publicado: (2017)

Histological transformation of adenocarcinoma to small cell carcinoma lung as a rare mechanism of resistance to epidermal growth factor receptor-tyrosine kinase inhibitors: Report of a case with review of literature
por: Hui, Monalisa, et al.
Publicado: (2018)

Effect of serum albumin level on high-dose methotrexate induced toxicities in acute lymphoblastic leukemia patients
por: Mirza, Mehdi Ali, et al.
Publicado: (2023)

456P Outcomes of COVID-19 infection in cancer patients: A single center study
por: Sindhu, S., et al.
Publicado: (2022)

Clinical profile and outcome of adult Hodgkin lymphoma: Experience from a tertiary care institution
por: Maddi, Rahul Narayan, et al.
Publicado: (2015)

Metastatic adenocarcinoma in a young male, 12 years after treatment of primary non seminomatous germ cell tumor
por: Coca, Pragnya, et al.
Publicado: (2011)

Renal Lymphoma: Primary or First Manifestation of Aggressive Pediatric B-cell Lymphoma
por: Coca, Pragnya, et al.
Publicado: (2017)

Epedimiologic, clinical profile and factors affecting the outcome in febrile neutropenia
por: Krishnamani, Kalpathi, et al.
Publicado: (2017)

Primary pleuropulmonary synovial sarcoma: A report of two cases and review of literature
por: Kalpathi, Krishnamani, et al.
Publicado: (2013)

Impact of COVID-19 infection among myasthenia gravis patients- a Cerner Real-World Data(TM) study
por: Digala, Lakshmi Prasanna, et al.
Publicado: (2022)

Real-world management of patients with epidermal growth factor receptor (EGFR) mutation-positive non–small-cell lung cancer in the USA
por: Li, Yulin, et al.
Publicado: (2019)

Real-world use of osimertinib for epidermal growth factor receptor T790M-positive non-small cell lung cancer in Japan
por: Ohe, Yuichiro, et al.
Publicado: (2020)

Acute myeloid leukaemia: challenges and real world data from India
por: Philip, Chepsy, et al.
Publicado: (2015)

Correction: Real-world management of patients with epidermal growth factor receptor (EGFR) mutation-positive non-small-cell lung cancer in the USA
por: Li, Yulin, et al.
Publicado: (2019)

Clinical Profile and Outcome of Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer With Brain Metastases: Real-World Experience
por: Bhargava, Prabhat, et al.
Publicado: (2022)

Efficacy and Safety of Pyrotinib in Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Multicenter, Retrospective, Real-World Study
por: Zhang, Xiaoling, et al.
Publicado: (2022)

Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation–Positive Non–Small Cell Lung Cancer
por: Lee, Jang Ho, et al.
Publicado: (2023)

Real World Experience of Second-Line Treatment Strategies after Palbociclib and Letrozole: Overall Survival in Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer
por: Kim, Ji-Yeon, et al.
Publicado: (2023)

Kinase domain mutations and responses to dose escalation in chronic myeloid leukemia resistant to standard dose imatinib mesylate
por: Rajappa, Senthil, et al.
Publicado: (2013)

Parasagittal hemangiopericytoma with late presentation of liver metastases: Case report and review of literature
por: Krishnamani, Kalpathi V., et al.
Publicado: (2013)

Bilateral serous choroidal detachment in brucellosis and its management and outcome: Literature review and case report
por: Adusumilli, Himabindu, et al.
Publicado: (2020)

Real-World Treatment Patterns for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer in Europe and the United States
por: Caldeira, Rita, et al.
Publicado: (2016)

Leptomeningeal metastases in patients with human epidermal growth factor receptor 2 positive breast cancer: Real‐world data from a multicentric European cohort
por: Ratosa, Ivica, et al.
Publicado: (2022)

Neoadjuvant therapy for early human epidermal growth factor receptor 2 positive breast cancer in China: A multicenter real-world study (CSBrS-015)
por: Cheng, Yuanjia, et al.
Publicado: (2022)

Growth Hormone Treatment in Turner's Syndrome: A Real World Experience
por: Reddy Danda, Vijay Sheker, et al.
Publicado: (2017)

Efficacy of Neoadjuvant Chemotherapy with Epirubicin and Cyclophosphamide and Weekly Paclitaxel and Trastuzumab in Human Epidermal Growth Factor Receptor 2–Positive Breast Carcinoma: A Real-World Study
por: Zhang, Mengmeng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ecrt72t980vfkftkvu8bm2v7e0